Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Hauser

Showing results (261-270 of 322) with videos related to

Pageof 33
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2019
A specific amino acid motif of <i>HLA-DRB1</i> mediates risk and interacts with smoking history in Parkinson's diseaseJill A Hollenbach, Paul J Norman, Lisa E Creary, et al.
Plos One|July 2, 2010
A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01Bruce A C Cree, John D Rioux, Jacob L McCauley, et al.
Neurology|October 15, 2017
Infliximab for the treatment of CNS sarcoidosis: A multi-institutional seriesJeffrey M Gelfand, Michael J Bradshaw, Barney J Stern, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 30, 2022
Remote Observational Research for Multiple Sclerosis: A Natural ExperimentRiley Bove, Shane Poole, Richard Cuneo, et al.
Nature Genetics|July 31, 2007
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosisSimon G Gregory, Silke Schmidt, Puneet Seth, et al.
Human Molecular Genetics|August 12, 2010
Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individualsFarren B S Briggs, Selena E Bartlett, Benjamin A Goldstein, et al.
Nature Genetics|September 28, 2005
A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibilityDavid Reich, Nick Patterson, Philip L De Jager, et al.
The New England Journal of Medicine|August 7, 2020
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, et al.
Brain : a Journal of Neurology|March 31, 2015
An ImmunoChip study of multiple sclerosis risk in African AmericansNoriko Isobe, Lohith Madireddy, Pouya Khankhanian, et al.
JAMA Neurology|June 9, 2015
Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple SclerosisRegina Schlaeger, Nico Papinutto, Alyssa H Zhu, et al.
Pageof 33

Showing results (261-270 of 322) with videos related to

Sort By:
Pageof 33
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2019
A specific amino acid motif of <i>HLA-DRB1</i> mediates risk and interacts with smoking history in Parkinson's diseaseJill A Hollenbach, Paul J Norman, Lisa E Creary, et al.
Plos One|July 2, 2010
A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01Bruce A C Cree, John D Rioux, Jacob L McCauley, et al.
Neurology|October 15, 2017
Infliximab for the treatment of CNS sarcoidosis: A multi-institutional seriesJeffrey M Gelfand, Michael J Bradshaw, Barney J Stern, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 30, 2022
Remote Observational Research for Multiple Sclerosis: A Natural ExperimentRiley Bove, Shane Poole, Richard Cuneo, et al.
Nature Genetics|July 31, 2007
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosisSimon G Gregory, Silke Schmidt, Puneet Seth, et al.
Human Molecular Genetics|August 12, 2010
Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individualsFarren B S Briggs, Selena E Bartlett, Benjamin A Goldstein, et al.
Nature Genetics|September 28, 2005
A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibilityDavid Reich, Nick Patterson, Philip L De Jager, et al.
The New England Journal of Medicine|August 7, 2020
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, et al.
Brain : a Journal of Neurology|March 31, 2015
An ImmunoChip study of multiple sclerosis risk in African AmericansNoriko Isobe, Lohith Madireddy, Pouya Khankhanian, et al.
JAMA Neurology|June 9, 2015
Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple SclerosisRegina Schlaeger, Nico Papinutto, Alyssa H Zhu, et al.
Pageof 33